Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multivalent antibody-based conjugates as new tools for tailored modulation of G protein-coupled receptors.

British journal of pharmacology·2026
Same author

Modulation of Ube2R1 activity by a nanobody that binds near its N-terminus.

The Biochemical journal·2026
Same author

Nanobody-Based Bioconjugates as Potent and Broadly Active Inhibitors of HIV Entry.

Journal of the American Chemical Society·2026
Same author

Development of bitopic nanobody-ligand conjugates targeting G protein-coupled receptors and exhibiting logic-gated signaling.

PLoS biology·2025
Same author

A modular Uba1-nanobody fusion enables selective ubiquitin transfer to tagged E2 enzymes.

The Journal of biological chemistry·2025
Same author

A multivalent nanobody-drug conjugate to prevent and treat influenza virus infections.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same journal

Wanted and unwanted modifications of mRNA, and their effect on gene expression and signaling.

The Journal of biological chemistry·2026
Same journal

TGF-β2 drives lipid droplet accumulation in chondrocytes through the TβRI/p-Smad3/Fabp5 axis.

The Journal of biological chemistry·2026
Same journal

Macrophage-specific targeting of histone demethylases with small-molecule inhibitors suppresses inflammatory response in vivo.

The Journal of biological chemistry·2026
Same journal

Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.

The Journal of biological chemistry·2026
Same journal

Correction: Characterization of Mast2 kinase defines structural features, regulation, and substrates.

The Journal of biological chemistry·2026
Same journal

Isotope-Edited ESEEM: A New Method for Probing Copper Binding Sites in Neurodegenerative Proteins.

The Journal of biological chemistry·2026
See all related articles

Related Experiment Video

Updated: Dec 10, 2025

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells
11:05

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells

Published on: February 21, 2019

9.5K

Exploring cellular biochemistry with nanobodies.

Ross W Cheloha1, Thibault J Harmand1, Charlotte Wijne1

  • 1Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.

The Journal of Biological Chemistry
|September 2, 2020
PubMed
Summary
This summary is machine-generated.

Camelid-derived nanobodies offer stable, cost-effective alternatives to conventional antibodies. These single-domain antibody fragments provide unique tools for biological research and medical applications, overcoming limitations of traditional antibody engineering.

Keywords:
antibody engineeringcell signalingprotein chemistrysingle-domain antibody (SdAb)synthetic biology

More Related Videos

Live-cell Imaging of Endocytic Transport using Functionalized Nanobodies in Cultured Cells
08:02

Live-cell Imaging of Endocytic Transport using Functionalized Nanobodies in Cultured Cells

Published on: October 17, 2025

474
Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

12.0K

Related Experiment Videos

Last Updated: Dec 10, 2025

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells
11:05

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells

Published on: February 21, 2019

9.5K
Live-cell Imaging of Endocytic Transport using Functionalized Nanobodies in Cultured Cells
08:02

Live-cell Imaging of Endocytic Transport using Functionalized Nanobodies in Cultured Cells

Published on: October 17, 2025

474
Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

12.0K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Immunology

Background:

  • Conventional antibodies are crucial for biological research and medicine but face challenges in production cost, engineering, and stability, especially in cellular environments.
  • Heavy chain-only antibodies from camelids have been engineered into single-domain antibody fragments (nanobodies) to address these limitations.

Purpose of the Study:

  • To review recent applications of nanobodies in biological exploration and medicine.
  • To highlight how nanobodies' unique properties, when combined with methods like chemical functionalization, create novel research and therapeutic tools.

Main Methods:

  • Review of existing literature on nanobody applications.
  • Analysis of case studies combining nanobodies with chemical functionalization.

Main Results:

  • Nanobodies serve as effective crystallization chaperones and alternatives to conventional antibodies.
  • Unique properties of nanobodies enable applications where standard antibodies are impractical.
  • Chemical functionalization enhances nanobody utility, yielding versatile tools.

Conclusions:

  • Nanobodies present a promising alternative to conventional antibodies due to their stability, engineerability, and cost-effectiveness.
  • The combination of nanobodies with other techniques expands their potential in biological research and medical applications.